183 related articles for article (PubMed ID: 21717191)
1. Underexpression of TIM-3 and blunted galectin-9-induced apoptosis of CD4+ T cells in rheumatoid arthritis.
Lee J; Park EJ; Noh JW; Hwang JW; Bae EK; Ahn JK; Koh EM; Cha HS
Inflammation; 2012 Apr; 35(2):633-7. PubMed ID: 21717191
[TBL] [Abstract][Full Text] [Related]
2. Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis.
Lee J; Oh JM; Hwang JW; Ahn JK; Bae EK; Won J; Koh EM; Cha HS
Scand J Rheumatol; 2011; 40(5):334-40. PubMed ID: 21446887
[TBL] [Abstract][Full Text] [Related]
3. Elevated Galectin-9 Suppresses Th1 Effector Function and Induces Apoptosis of Activated CD4
Yang S; Wang J; Chen F; Liu G; Weng Z; Chen J
Inflammation; 2017 Jun; 40(3):1062-1071. PubMed ID: 28393295
[TBL] [Abstract][Full Text] [Related]
4. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.
Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H
Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414
[TBL] [Abstract][Full Text] [Related]
5. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection.
Elahi S; Niki T; Hirashima M; Horton H
Blood; 2012 May; 119(18):4192-204. PubMed ID: 22438246
[TBL] [Abstract][Full Text] [Related]
6. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4
Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH
Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217
[TBL] [Abstract][Full Text] [Related]
7. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts.
Seki M; Sakata KM; Oomizu S; Arikawa T; Sakata A; Ueno M; Nobumoto A; Niki T; Saita N; Ito K; Dai SY; Katoh S; Nishi N; Tsukano M; Ishikawa K; Yamauchi A; Kuchroo V; Hirashima M
Arthritis Rheum; 2007 Dec; 56(12):3968-76. PubMed ID: 18050192
[TBL] [Abstract][Full Text] [Related]
9. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
[TBL] [Abstract][Full Text] [Related]
10. [Impaired apoptosis of peripheral blood CD4+T cells in patients with rheumatoid arthritis].
Cao Y; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):682-5, 688. PubMed ID: 25940298
[TBL] [Abstract][Full Text] [Related]
11. Expression of TIM-3 on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid of rheumatoid arthritis.
Li S; Peng D; He Y; Zhang H; Sun H; Shan S; Song Y; Zhang S; Xiao H; Song H; Zhang M
APMIS; 2014 Oct; 122(10):899-904. PubMed ID: 24689929
[TBL] [Abstract][Full Text] [Related]
12. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
13. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis.
Saresella M; Piancone F; Marventano I; La Rosa F; Tortorella P; Caputo D; Rovaris M; Clerici M
FASEB J; 2014 Nov; 28(11):5000-9. PubMed ID: 25091272
[TBL] [Abstract][Full Text] [Related]
14. Analysis of PD-1 and Tim-3 expression on CD4
Koohini Z; Hossein-Nataj H; Mobini M; Hosseinian-Amiri A; Rafiei A; Asgarian-Omran H
Clin Rheumatol; 2018 Aug; 37(8):2063-2071. PubMed ID: 29626269
[TBL] [Abstract][Full Text] [Related]
15. High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis.
Song L; Wang Y; Sui Y; Sun J; Li D; Li G; Liu J; Li T; Shu Q
Med Sci Monit; 2018 Aug; 24():5660-5667. PubMed ID: 30106887
[TBL] [Abstract][Full Text] [Related]
16. T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis.
Li X; Zhao YQ; Li CW; Yuan FL
Expert Opin Ther Targets; 2012 Dec; 16(12):1145-9. PubMed ID: 22998573
[TBL] [Abstract][Full Text] [Related]
17. Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity.
Liu Y; Shu Q; Gao L; Hou N; Zhao D; Liu X; Zhang X; Xu L; Yue X; Zhu F; Guo C; Liang X; Ma C
Clin Immunol; 2010 Nov; 137(2):288-95. PubMed ID: 20805041
[TBL] [Abstract][Full Text] [Related]
18. Galectin-9 contributes to the pathogenesis of atopic dermatitis
Su W; Zhang J; Yang S; Tang M; Shen Y; Liu C; Ji J; Maurer M; Jiao Q
Front Immunol; 2022; 13():952338. PubMed ID: 35967337
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia.
Miko E; Meggyes M; Bogar B; Schmitz N; Barakonyi A; Varnagy A; Farkas B; Tamas P; Bodis J; Szekeres-Bartho J; Illes Z; Szereday L
PLoS One; 2013; 8(8):e71811. PubMed ID: 23936526
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy.
Meggyes M; Miko E; Polgar B; Bogar B; Farkas B; Illes Z; Szereday L
PLoS One; 2014; 9(3):e92371. PubMed ID: 24651720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
